Patterns of Emphysema Heterogeneity

Respiration

Volumn 90, Issue 5, 2015, Pages 402-411

  Valipour, Arschang ^a   Shah, Pallav L ^b   Gesierich, Wolfgang ^c   Eberhardt, Ralf ^d   Snell, Greg ^e   Strange, Charlie ^f   Barry, Robert ^g   Gupta, Avina ^g   Henne, Erik ^g   Bandyopadhyay, Sourish ^g   Raffy, Philippe ^h   Yin, Youbing ^h   Tschirren, Juerg ^h   Herth, Felix J F ^d  

^a OTTO WAGNER HOSPITAL   (Austria)

^b ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^c ASKLEPIOS FACHKLINIKEN MÜNCHEN GAUTING   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e ALFRED HOSPITAL   (Australia)

^f MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^g Uptake Medical Corp   (United States)

^h VIDA Diagnostics   (United States)

Author keywords

Bronchoscopy; Chronic obstructive pulmonary disease; Computed tomography; Heterogeneity; Lung volume reduction

Indexed keywords

AGED; ALPHA ANTITRYPSIN DEFICIENCY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; FEMALE; HUMAN; LUNG EMPHYSEMA; LUNG FUNCTION; LUNG RESECTION; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; COHORT ANALYSIS; DIAGNOSTIC IMAGING; IMAGE PROCESSING; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PREOPERATIVE CARE; PROCEDURES; PROSPECTIVE STUDY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; THREE DIMENSIONAL IMAGING; X-RAY COMPUTED TOMOGRAPHY;

AGED; COHORT STUDIES; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MALE; MIDDLE AGED; PNEUMONECTOMY; PREOPERATIVE CARE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84948085987     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000439544     Document Type: Article

References (25)

1. O'Donnell DE, Laveneziana P: Physiology and consequences of lung hyperinflation in COPD. Eur Respir Rev 2006; 15:61-67.
2. Sanchez PG, Kucharczuk JC, Su S, Kaiser LR, Cooper JD: National Emphysema Treatment Trial redux: accentuating the positive. J Tho-rac Cardiovasc Surg 2010; 140:564-572.
3. Madani A, Keyzer C, Gevenois P: Quantitative computed tomography assessment of lung structure and function in pulmonary emphysema. Eur Respir J 2001; 18:720-730.
4. Weder W, Thurnheer R, Stammberger U, Bürge M, Russi EW, Bloch KE: Radiologic emphysema morphology is associated with outcome after surgical lung volume reduction. Ann Thorac Surg 1997; 64:313-319; discussion 319-320.
5. Valipour A, Herth FJF, Eberhardt R, Shah PL, Gupta A, Barry R, Henne E, Bandyopadhyay S, Snell G: Design of the randomized, controlled sequential staged treatment of emphysema with upper lobe predominance (STEP-UP) study. BMC Pulm Med 2014; 14:190.
6. Sciurba FC, Ernst A, Herth FJF, Strange C, Criner GJ, Marquette CH, Kovitz KL, Chia-cchierini RP, Goldin J, McLennan G: A randomized study of endobronchial valves for advanced emphysema. N Engl J Med 2010; 363:1233-1244.
7. Hurst JR, Vestbo J, Anzueto A, Locantore N, Müllerova H, Tal-Singer R, Miller B, Lomas DA, Agusti A, MacNee W, Calverley P, Ren-nard S, Wouters E, Wedzicha JA: Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010; 363: 1128-1138.
8. Agusti A, Calverley PMA, Celli B, Coxson HO, Edwards LD, Lomas DA, MacNee W, Miller BE, Rennard S, Silverman EK, Tal-Singer R, Wouters E, Yates JC, Vestbo J: Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010; 11:122.
9. Watz H, Waschiki B, Meyer T, Magnussen H: Physical activity in patients with COPD. Eur Respir J 2009; 33:262-272.
10. Mahler DA, Ward J, Waterman LA, McCusk-er C, Zuwallack R, Baird JC: Patient-reported dyspnea in COPD reliability and association with stage of disease. Chest 2009; 136:1473-1479.
11. Regan EA, Hokanson JE, Murphy JR, Make B, Lynch DA, Beaty TH, Curran-Everett D, Sil-verman EK, Crapo JD: Genetic epidemiology of COPD (COPDGene) study design. COPD 2010; 7:32-43.
12. Schuhmann M, Raffy P, Yin Y, Gompelmann D, Oguz I, Eberhardt R, Hornberg D, Heussel CP, Wood S, Herth FJF: Computed tomography predictors of response to endobronchial valve lung reduction treatment. Comparison with Chartis. Am J Respir Crit Care Med 2015; 191:767-774.
13. Heremans A, Verschakelen JA, Demedts M: Measurement of lung density by means of quantitative CT scanning. A study of correlations with pulmonary function tests. Chest 1992; 102:805-811.
14. Bandyopadhyay S, Henne E, Gupta A, Barry R, Snell G, Strange C, Herth FJF: Segmental approach to lung volume reduction therapy for emphysema patients. Respiration 2015; 89: 76-81.
15. Fishman A, Martinez F, Naunheim K, Pianta-dosi S, Wise R, Ries A, Weinmann G, Wood DE: A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003; 348:2059-2073.
16. Higuchi T, Reed A, Oto T, Holsworth L, Ellis S, Bailey MJ, Williams TJ, Snell G: Relation of interlobar collaterals to radiological heterogeneity in severe emphysema. Thorax 2006; 61: 409-413.
17. Herth FJF, Noppen M, Valipour A, Leroy S, Vergnon J, Ficker JH, Egan JJ, Gasparini S, Agusti C, Holmes-Higgin D, Ernst A: Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort. Eur Respir J 2012; 39:1334-1342.
18. Herth FJF, Gompelmann D, Ernst A, Eber-hardt R: Endoscopic lung volume reduction. Respiration 2009; 79:5-13.
19. Shah PL, Hopkinson NS: Bronchoscopic lung volume reduction for emphysema: where next? Eur Respir J 2012; 39:1287-1289.
20. Gompelmann D, Eberhardt R, Herth F: Endo-scopic volume reduction in COPD-a critical review. Dtsch Arztebl Int 2014; 111:827-833.
21. Storbeck B, Schröder TH, Oldigs M, Rabe KF, Weber C: Emphysema: imaging for endo-scopic lung volume reduction. Rofo 2015; 187: 543-554.
22. Dirksen A, Dijkman JH, Madsen F, Stoel B, Hutchison DCS, Ulrik CS, Skovgaard LT, Kok-Jensen A, Rudolphus A, Seersoholdm N, Vrooman HA, Reiber JHC, Hansen NC, Heckscher T, Viskum K, Stolk J: A randomized clinical trial of α1-antitrypsin augmentation therapy. Am J Respir Crit Care Med 1999; 160:1468-1472.
23. Bakke PS, Baste V, Hanoa R, Gulsvik A: Prevalence of obstructive lung disease in a general population: relation to occupational title and exposure to some airborne agents. Thorax 1991; 46:863-870.
24. Mannino DM, Buist AS: Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007; 370:765-773.
25. Doellinger F, Huebner RH, Kuhnigk JM, Poellinger A: Lung volume reduction in pulmonary emphysema from the radiologist's perspective. Rofo 2015; 187:662-675.